Literature DB >> 11118583

Secretion of biologically active murine interleukin-10 by Lactococcus lactis.

.   

Abstract

We investigated the ability of Lactococcus lactis to secrete biologically active, murine interleukin-10 (mIL-10). mIL-10 was synthesized as a fusion protein, consisting of the mature part of the eukaryotic protein fused to the secretion signal of the lactococcal Usp45 protein. The secreted protein was analyzed by PAGE, ELISA and bioassay.We show that L. lactis can efficiently secrete biologically active, murine IL-10. Determination of the N-terminal amino acid sequence confirmed correct processing of the fusion polypeptide by the lactococcal signal peptidase. The amount of mIL-10, accumulating in the medium, could be increased by a factor of ten by growing the cells in an optimized medium, buffered at near-neutral pH. Under these conditions, up to 30 mg of mIL-10 was obtained from a 10-litre fermentation.

Entities:  

Year:  2000        PMID: 11118583     DOI: 10.1016/s0141-0229(00)00297-0

Source DB:  PubMed          Journal:  Enzyme Microb Technol        ISSN: 0141-0229            Impact factor:   3.493


  28 in total

1.  Influence of two-component signal transduction systems of Lactobacillus casei BL23 on tolerance to stress conditions.

Authors:  Cristina Alcántara; Ainhoa Revilla-Guarinos; Manuel Zúñiga
Journal:  Appl Environ Microbiol       Date:  2010-12-23       Impact factor: 4.792

Review 2.  Therapeutic approaches targeting intestinal microflora in inflammatory bowel disease.

Authors:  Akira Andoh; Yoshihide Fujiyama
Journal:  World J Gastroenterol       Date:  2006-07-28       Impact factor: 5.742

3.  A Recombinant Probiotic, Lactobacillus casei, Expressing the Clostridium perfringens α-toxoid, as an Orally Vaccine Candidate Against Gas Gangrene and Necrotic Enteritis.

Authors:  Mojtaba Alimolaei; Mehdi Golchin; Jalil Abshenas; Majid Ezatkhah; Mehrdad Shamsaddini Bafti
Journal:  Probiotics Antimicrob Proteins       Date:  2018-06       Impact factor: 4.609

Review 4.  Probiotics: properties, examples, and specific applications.

Authors:  Judith Behnsen; Elisa Deriu; Martina Sassone-Corsi; Manuela Raffatellu
Journal:  Cold Spring Harb Perspect Med       Date:  2013-03-01       Impact factor: 6.915

5.  Malic enzyme and malolactic enzyme pathways are functionally linked but independently regulated in Lactobacillus casei BL23.

Authors:  José María Landete; Sergi Ferrer; Vicente Monedero; Manuel Zúñiga
Journal:  Appl Environ Microbiol       Date:  2013-07-08       Impact factor: 4.792

6.  Recommendations for improved use of the murine TNBS-induced colitis model in evaluating anti-inflammatory properties of lactic acid bacteria: technical and microbiological aspects.

Authors:  Benoit Foligné; Sophie Nutten; Lothar Steidler; Véronique Dennin; Denise Goudercourt; Annick Mercenier; Bruno Pot
Journal:  Dig Dis Sci       Date:  2006-02       Impact factor: 3.199

7.  Regulation of Lactobacillus casei sorbitol utilization genes requires DNA-binding transcriptional activator GutR and the conserved protein GutM.

Authors:  Cristina Alcántara; Luz Adriana Sarmiento-Rubiano; Vicente Monedero; Josef Deutscher; Gaspar Pérez-Martínez; María J Yebra
Journal:  Appl Environ Microbiol       Date:  2008-08-01       Impact factor: 4.792

8.  Novel xylan-controlled delivery of therapeutic proteins to inflamed colon by the human anaerobic commensal bacterium.

Authors:  Z Z R Hamady
Journal:  Ann R Coll Surg Engl       Date:  2013-05       Impact factor: 1.891

9.  Requirement of the Lactobacillus casei MaeKR two-component system for L-malic acid utilization via a malic enzyme pathway.

Authors:  José María Landete; Luisa García-Haro; Amalia Blasco; Paloma Manzanares; Carmen Berbegal; Vicente Monedero; Manuel Zúñiga
Journal:  Appl Environ Microbiol       Date:  2009-11-06       Impact factor: 4.792

10.  Identification and characterization of the novel LysM domain-containing surface protein Sep from Lactobacillus fermentum BR11 and its use as a peptide fusion partner in Lactobacillus and Lactococcus.

Authors:  Mark S Turner; Louise M Hafner; Terry Walsh; Philip M Giffard
Journal:  Appl Environ Microbiol       Date:  2004-06       Impact factor: 4.792

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.